Search Results 1121-1130 of 18074 for multiple%20sclerosis
2024 Dec; 20 Suppl 3:e085612. View PubMed; Boots EA ... 2024 Dec; 20 Suppl 3:e085992 ... Liver kinase B1 rs9282860 polymorphism and risk for multiple sclerosis in ...
In another project, Mayo Clinic has licensed a bacteria to a biotechnology company for further study about its role in suppressing multiple sclerosis and ...
Multiple Sclerosis and Autoimmune Neurology · Neuromuscular Diseases · Neuro-Oncology · Pain and Headache · Sleep Neurology · Spinal Cord Disorders · Clinical ...
SGN-CD352A will be given every 4 weeks to a small group of patients with multiple myeloma. Participation eligibility. Participant eligibility includes age ...
Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18 ... August 20, 2013. First · Previous ... 340 · 341 · 342 · 343 · 344 · 345 · 346 ...
FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...
May 20, 2014. Cancer. Mayo Clinic First to Show Virotherapy is Promising Against Multiple Myeloma (pkg). Robert Nellis. May 16, 2014. Minnesota. Mayo Study ...
Study identifies barriers to transplant therapy to treat multiple myeloma among racial minority groups featured image. Cancer. Study identifies barriers to ...
Aging · Alzheimer's disease · Cerebellar ataxias · Cerebrovascular diseases · Frontotemporal dementia & amyotrophic lateral sclerosis · Neurotherapeutics.
2022 Gerstner Awardee to investigate dual CAR-T cell therapy for multiple myeloma cancer. Susan Murphy. July 20, 2022. Mobile app for improving heart health ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.